ArticleExperimental dermatology2013
Vitiligo and alopecia areata: apples and oranges?
Article in Experimental dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 72 citations in OpenAlex.
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation.Journal of clinical medicine · 2025Article
- Vitiligo is associated with lower body mass index: a retrospective case-control study.The British journal of dermatology · 2025Article
- Hair regrowth in alopecia areata and re-pigmentation in vitiligo in response to treatment: Commonalities and differences.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Review
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences.International journal of molecular sciences · 2024Review
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata.eLife · 2023Article
- Beyond skin white spots: Vitiligo and associated comorbidities.Frontiers in medicine · 2023Review
- Hair Follicle Melanocytes Initiate Autoimmunity in Alopecia Areata: a Trigger Point.Clinical reviews in allergy & immunology · 2022Review
- Videodermoscopic Changes of the Hair in Vitiligo Lesions in Relation to Disease Duration.Dermatology practical & conceptual · 2022Article
- Hair Follicle Melanogenesis Reflected in Hair Pigmentation as a Developmental Factor in Alopecia Areata.Skin appendage disorders · 2021Article
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review.Annals of dermatology · 2021Article
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.Clinical and experimental medicine · 2021Review
- Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo.Dermatology research and practice · 2021Article
- Increased Serum Levels of IFN-Oxidative medicine and cellular longevity · 2020Article
- Ischemic modified albumin as a new biomarker in predicting oxidative stress in alopecia areataTurkish journal of medical sciences · 2019Article
- Nivolumab-induced alopecia areata: A reversible factor of good prognosis?JAAD case reports · 2018Article
- Next generation human skin constructs as advanced tools for drug development.Experimental biology and medicine (Maywood, N.J.) · 2017Review
- Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.Journal of the American Academy of Dermatology · 2017Article
- Article
- Understanding autoimmunity of vitiligo and alopecia areata.Current opinion in pediatrics · 2016Review
- Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.Annals of translational medicine · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Vitiligo and alopecia areata are common autoimmune diseases of the skin. Vitiligo is caused by the destruction of melanocytes and results in the appearance of white patches on any part of the body, while alopecia areata is characterized by patchy hair loss primarily on the scalp, but may also involve other areas as well. At first glance, the two diseases appear to be quite different, targeting different cell types and managed using different treatment approaches. However, the immune cell populations and cytokines that drive each disease are similar, they are closely associated within patients and their family members, and vitiligo and alopecia areata have common genetic risk factors, suggesting that they share a similar pathogenesis. Like apples and oranges, vitiligo and alopecia areata have some obvious differences, but similarities abound. Recognizing both similarities and differences will promote research into the pathogenesis of each disease, as well as the development of new treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.